Harbor Investment Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.3K Hold
612
0.01% 633
2026
Q1
$85.3K Sell
612
-156
-20% -$21.8K 0.01% 534
2025
Q4
$94.3K Buy
768
+472
+159% +$57.4K 0.01% 523
2025
Q3
$32.9K Buy
296
+77
+35% +$8.75K ﹤0.01% 706
2025
Q2
$24.3K Buy
219
+7
+3% +$745 ﹤0.01% 757
2025
Q1
$23.8K Buy
212
+19
+10% +$1.96K ﹤0.01% 749
2024
Q4
$17.8K Hold
193
﹤0.01% 769
2024
Q3
$16.2K Sell
193
-9
-4% -$687 ﹤0.01% 786
2024
Q2
$13.9K Sell
202
-82
-29% -$5.47K ﹤0.01% 797
2024
Q1
$20.8K Buy
284
+93
+49% +$7.15K ﹤0.01% 732
2023
Q4
$15.5K Sell
191
-134
-41% -$10.4K ﹤0.01% 757
2023
Q3
$24.4K Buy
325
+134
+70% +$10.3K ﹤0.01% 663
2023
Q2
$14.7K Buy
191
+50
+35% +$3.99K ﹤0.01% 953
2023
Q1
$11.7K Sell
141
-15
-10% -$1.24K ﹤0.01% 1005
2022
Q4
$13.4K Sell
156
-40
-20% -$3.17K ﹤0.01% 976
2022
Q3
$12K Buy
196
+55
+39% +$3.47K ﹤0.01% 1010
2022
Q2
$9K Hold
141
﹤0.01% 1045
2022
Q1
$8K Sell
141
-30
-18% -$1.92K ﹤0.01% 1089
2021
Q4
$12K Hold
171
﹤0.01% 1024
2021
Q3
$12K Hold
171
﹤0.01% 1024
2021
Q2
$12K Sell
171
-200
-54% -$13.4K ﹤0.01% 980
2021
Q1
$24K Buy
371
+77
+26% +$4.96K ﹤0.01% 851
2020
Q4
$17K Sell
294
-197
-40% -$11.9K ﹤0.01% 849
2020
Q3
$31K Sell
491
-31
-6% -$2.15K 0.01% 631
2020
Q2
$40K Buy
522
+380
+268% +$29.1K 0.01% 483
2020
Q1
$11K Buy
142
+51
+56% +$3.52K ﹤0.01% 717
2019
Q4
$6K Buy
+91
New +$5.93K ﹤0.01% 693

Other funds holding GILD

Harbor Investment Advisory's GILD Position: Q2 2026 in Review

Harbor Investment Advisory held its Gilead Sciences (GILD) position steady in Q2 2026 at 612 shares worth $77.3K. The position accounts for 0.01% of the portfolio, ranked #633.

Harbor Investment Advisory first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $94.3K in Q4 2025. 804 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Harbor Investment Advisory held 612 shares of Gilead Sciences worth $77.3K as of Q2 2026.
  • Harbor Investment Advisory left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #633 holding.
  • Harbor Investment Advisory first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Gilead Sciences position peaked at $94.3K in Q4 2025.
  • 804 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.